Prophylactic or therapeutic agent for amnesia
AssigneeDaiichi Pharmaceutical Co., Ltd.
InventorsCiaran Regan, David O'Gorman, Alan O'Connell, Tadashi Shiotani
Life of this patent
Estimating the term…
Abstract
A medicament comprising as an active ingredient a compound represented by the following formula: R2—CH2CONH—R1 wherein R1 represents pyridyl group, a substituted pyridyl group, phenyl group, or a substituted phenyl group; and R2 represents a 2-oxo-1-phyrrolidinyl group which may be substituted (e.g., N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide), which is useful for preventive and/or therapeutic treatment of amnesia caused by, for example, an anesthetic agent for intravenous administration such as propofol.
Claims18
A medicament for preventive and/or therapeutic treatment of amnesia caused by general anesthesia which comprises as an active ingredient N-(2,6-dimethyl-phenyl)-2-(2-oxo-1-pyrrolidinyl) acetamide in an effective amount for the preventive and/or therapeutic treatment of amnesia caused by general anesthesia.
A method for preventive and/or therapeutic treatment of amnesia caused by general anesthesia which comprises:
- administering to a patent an amount of N-(2,6-dimethyl-phenyl)-2-(2-oxo-1-pyrrolidinyl) acetamide effective for the preventive and/or therapeutic treatment of amnesia.
A method for therapeutic treatment of amnesia caused by general anesthesia which comprises:
- administering to a patent an amount of N-(2,6-dimethyl-phenyl)-2-(2-oxo-1-pyrrolidinyl) acetamide effective for the therapeutic treatment of amnesia.
Dependencies are inferred from the claim text.